Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#1775 Potential Therapeutic Targets for Gastric Poorly Differentiated Neuroendocrine Carcinoma
Introduction: Gastric poorly differentiated neuroendocrine carcinoma (G-PDNEC) is rare and aggressive. Patients often present with distant metastases at initial diagnosis.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: JI Y
Authors: Ji Y, Xie Y, Chen K, Zeng H, Sun Y,
Keywords: gastric, neuroendocrine carcinoma, mTOR pathway, SSTR, targeted therapies,
Introduction: Recent studies have shown that Pancreatic neuroendocrine carcinomas (NECs) contain well-differentiated NETs with high proliferative activity (WDNET-G3), as well as poorly differentiated NECs (PDNECs). Although patients with pNEC show variable responses to platinum-based chemotherapy, predictors of the response are unknown.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Hijioka S
Authors: Hijioka S, Hosoda W, Matsuo k, Ueno M, Furukawa M,
Introduction: Recent studies have shown that Pancreatic neuroendocrine carcinomas (NECs) contain well-differentiated NETs with high proliferative activity (WDNET-G3), as well as poorly differentiated NECs (PDNECs). Although patients with pNEC show variable responses to platinum-based chemotherapy, predictors of the response are unknown.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Hijioka S
Authors: Hijioka S,
#1290 PD-L1 Expression is Associated with Grade of Neuroendocrine Tumors
Introduction: Neuroendocrine neoplasms are divided into well-differentiated neuroendocrine tumors (WDNETs) and poorly differentiated neuroendocrine carcinomas (PDNECs).The correlation between Gastroenteropancreatic Neuroendocrine Neoplasms (GEPNENs) and immunocheck point molecule-PD-L1 is still unclear now.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Leng J
Authors: Li Z, Leng J, Wang H, Li S, Lu M,
Keywords: PD-L1, neuroendocrine tumor, grade,
Introduction: No standard chemotherapy is established for advanced poorly differentiated neuroendocrine carcinoma (PDNEC) originating from the gastrointestinal tract (GI) or the hepato-biliary-pancreatic system (HBP).
Conference: 10th Annual ENETSConcerence (2013)
Presenting Author: Tomohiro Y
Authors: Yamaguchi T, Machida N, Kasuga A, Takahashi H, Sudo K,
Keywords: poorly-differentiated, PDNEC, irinotecan, etoposide, gastrointestinal,